This site is new - feedback and suggestions welcome via GitHub issues.

#organoid — Tuesday, May 12, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy. (gut.bmj.com) robot Liu J … Hao J Gut 2026-05-12 #cancer #glycosylation #mutation #organoid #therapeutic resistance